Here's the deal: You may read the information on the site for free. As and when I have the time I'll add new articles, taking into account any questions which have been asked. For legal reasons, please do not consider anything on this site to be advice - the only free investment advice is to apply your own mind. If you want to request that an article be written, then email me. I have limited time available, and will prioritise the work accordingly, so please be patient. Email me at invest@freeinvestmentadvice.org.
John Daniel Holdings |
2012-01-02 John Daniel Holdings is a venture capital investment holding company, seeking out complementary companies with high barriers to entry & high profit margins. They are involved in stem cell storage, the table grape industry & microfinance.
Lazaron Biotechnologies was a trading subsidiary at the start of the period (1 Jul 2010). During the period the Group established a marketing channel & sales force in Lazaron, which resulted in a 32% increase in revenue (achieved in the last 6 months of the period), but also increased operating expenses. By 30 Sep 2011, this business was approaching breakeven performance.
Subject to shareholder approval, Lazaron will continue to provide the current servies but will also focus on stem cell therapies in the future, and will also pursue the equine therapy development.
Vinguard was a trading subsidiaries at the start of the period (1 Jul 2010).
Involved in the table grape industry (WHICH HAS VERY LITTLE OVERLAP WITH STEM CELL BANKS). "The company's operations involve a relatively extended production & working capital cycle". The last period saw a 90% reduction in turnover, which was off-set to an extent "by the reduction in operating expenses resulting from the rationalisation of Vinguard's operations".
"The board continues to drive efforts to diversify the Vinguard product offering into other produce markets as well as Northern Hemisphere production areas".
Cryo-Save N.V. is an international family stem cell bank, with expertise in stem cell processing & storage. On 2 Jun 2011 Cryo-Save Group N.V. & John Daniel Holdings signed a MOU to create a new stem cell bank in SA. On 1 Jul 2011 JDH acquired a 50% stake in Rexisource, trading as Cryo-Save SA. Cryo-Save SA provides clients the option of storing cord tissue & stem cells from cord blood in SA or Belgium.
Viscacom, trading as JDH Credit Services, was acquired on 1 Sep 2011 for a cash consideration of R100. JDH Credit Services is the first acquisition of the new Financial Services Division of JDH, & is a micro finance business providing financial services to 3rd party company employees. WHAT IS THEIR EDGE IN THE INCREASINGLY COMPETITIVE MICRO FINANCE ARENA? As at 30 Jun 2011 there was a loan book of R2.6m & 200 clients.
MICROFINANCE HAS VERY LITTLE OVERLAP WITH THE TABLE GRAPE INDUSTRY OR STEM CELL STORAGE.
Due to regulations, our emails and this entire website should be considered as having been set up for entertainment purposes alone. Expect errors and omissions. Investment in shares and other financial instruments should be conducted by professional investment experts only. Any use of the information on my websites, emails and newsletters is at your own risk, and by using it you agree that the owners of our websites, authors and associated parties wont be held liable for any losses suffered as a result of using the information. None of the information should be construed as being advice. Our newsletters, articles, discussions and website are not an offering for any investment. It represents only our and others' opinions. Any views expressed are provided for information purposes only and should not be construed in any way as an offer, an endorsement, or inducement to invest. Illustrations, forecasts or hypothetical data are not guaranteed and are provided for illustrative purposes only. There are risks involved in buying or selling a financial product. Past performance is not indicative of future performance. Any investment values given are not guaranteed. Investment returns can be volatile. When investing there is always the risk of losing all or a substantial amount of your investment, as well as the risk of illiquidity. There may be advertisements on some pages on this website, and we may earn income from these advertisements. We may earn commission on products invested in or annuities purchased. We cannot attest to the accuracy of the material presented here, and opinions expressed may be changed without prior notice. In any event our liability will be limited to R1, and any court cases must take place in Cape Town. You may contact us at invest@freeinvestmentadvice.org